Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Amy M. Hall"'
Autor:
Sarah Bazargan, Brittany Bunch, Awino Maureiq E. Ojwang‘, Jamie Blauvelt, Annick Landin, Johannes Ali, Dominique Abrahams, Cheryl Cox, Amy M. Hall, Matthew S. Beatty, Michael Poch, Katarzyna A. Rejniak, Shari Pilon-Thomas
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundNew therapeutics in development for bladder cancer need to address the recalcitrant nature of the disease. Intravesical adoptive cell therapy (ACT) with tumor infiltrating lymphocytes (TIL) can potentially induce durable responses in bladde
Externí odkaz:
https://doaj.org/article/6a8fb4e5eb7f4745af9760012bdd39fc
Autor:
Shari Pilon-Thomas, Daniel Abate-Daga, Amod A. Sarnaik, James J. Mule, Xiaoqing Yu, Patrick Innamarato, Jamie Blauvelt, Holly Branthoover, Jake Ceccarelli, TJ Langer, MacLean S. Hall, Jamie K. Teer, Sebastian Snedal, Madeline Rodriguez-Valentin, Luz Nagle, Ellen Scott, Ben Schachner, Amy M. Hall, Carolyn J. Rich, Allison D. Richards, Sean J. Yoder, Matthew S. Beatty, Cheryl A. Cox, Jane L. Messina, John E. Mullinax
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 10 (2023)
Background Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) is a promising immunotherapeutic approach for patients with advanced solid tumors. While numerous advances have been made, the contribution of neoantigen-specific CD4+T
Externí odkaz:
https://doaj.org/article/389eec90db77472d949e719312488bf2
Autor:
MacLean S. Hall, John E. Mullinax, Cheryl A. Cox, Amy M. Hall, Matthew S. Beatty, Jamie Blauvelt, Patrick Innamarato, Luz Nagle, Holly Branthoover, Doris Wiener, Benjamin Schachner, Alberto J. Martinez, Allison D. Richards, Carolyn J. Rich, Marjorie Colón Colón, Michael J. Schell, Jamie K. Teer, Nikhil I. Khushalani, Jeffrey S. Weber, James J. Mulé, Vernon K. Sondak, Shari Pilon-Thomas, Amod A. Sarnaik
Publikováno v:
Clin Cancer Res
Purpose: Metastatic melanoma is a tumor amenable to immunotherapy in part due to the presence of antigen-specific tumor-infiltrating lymphocytes (TIL). These T cells can be activated and expanded for adoptive cell transfer (ACT), which has resulted i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::079ac7f397d9831674a16a2454385b10
https://doi.org/10.1158/1078-0432.ccr-22-2103
https://doi.org/10.1158/1078-0432.ccr-22-2103
Autor:
Amod A. Sarnaik, Shari Pilon-Thomas, Vernon K. Sondak, James J. Mulé, Jeffrey S. Weber, Nikhil I. Khushalani, Jamie K. Teer, Michael J. Schell, Marjorie Colón Colón, Carolyn J. Rich, Allison D. Richards, Alberto J. Martinez, Benjamin Schachner, Doris Wiener, Holly Branthoover, Luz Nagle, Patrick Innamarato, Jamie Blauvelt, Matthew S. Beatty, Amy M. Hall, Cheryl A. Cox, John E. Mullinax, MacLean S. Hall
Purpose:Metastatic melanoma is a tumor amenable to immunotherapy in part due to the presence of antigen-specific tumor-infiltrating lymphocytes (TIL). These T cells can be activated and expanded for adoptive cell transfer (ACT), which has resulted in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7eb60366f45035c394e6def01013966
https://doi.org/10.1158/1078-0432.c.6532817.v1
https://doi.org/10.1158/1078-0432.c.6532817.v1
Autor:
Amod A. Sarnaik, Shari Pilon-Thomas, Vernon K. Sondak, James J. Mulé, Jeffrey S. Weber, Nikhil I. Khushalani, Jamie K. Teer, Michael J. Schell, Marjorie Colón Colón, Carolyn J. Rich, Allison D. Richards, Alberto J. Martinez, Benjamin Schachner, Doris Wiener, Holly Branthoover, Luz Nagle, Patrick Innamarato, Jamie Blauvelt, Matthew S. Beatty, Amy M. Hall, Cheryl A. Cox, John E. Mullinax, MacLean S. Hall
The Supplementary Methods Table contains the antibodies and panels in support of the Flow Cytometry section of the Materials and Methods.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0701b9fedc5cd28fd7c7f515e9e18fc1
https://doi.org/10.1158/1078-0432.22488845.v1
https://doi.org/10.1158/1078-0432.22488845.v1
Autor:
Amod A. Sarnaik, Shari Pilon-Thomas, Vernon K. Sondak, James J. Mulé, Jeffrey S. Weber, Nikhil I. Khushalani, Jamie K. Teer, Michael J. Schell, Marjorie Colón Colón, Carolyn J. Rich, Allison D. Richards, Alberto J. Martinez, Benjamin Schachner, Doris Wiener, Holly Branthoover, Luz Nagle, Patrick Innamarato, Jamie Blauvelt, Matthew S. Beatty, Amy M. Hall, Cheryl A. Cox, John E. Mullinax, MacLean S. Hall
Supplementary Figure 1 shows that central memory T cells were increase in the CD8+ TIL compartment of responders.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86694df9a2807d2cace95b7318bab8f5
https://doi.org/10.1158/1078-0432.22488848.v1
https://doi.org/10.1158/1078-0432.22488848.v1
Autor:
Amod A. Sarnaik, Shari Pilon-Thomas, Vernon K. Sondak, James J. Mulé, Jeffrey S. Weber, Nikhil I. Khushalani, Jamie K. Teer, Michael J. Schell, Marjorie Colón Colón, Carolyn J. Rich, Allison D. Richards, Alberto J. Martinez, Benjamin Schachner, Doris Wiener, Holly Branthoover, Luz Nagle, Patrick Innamarato, Jamie Blauvelt, Matthew S. Beatty, Amy M. Hall, Cheryl A. Cox, John E. Mullinax, MacLean S. Hall
Supplementary Table 2 contains the Representativeness Table which demonstrates how this study fits into the larger patient population for metastatic melanoma.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ee78a380478c7672e46fbf77da910f7
https://doi.org/10.1158/1078-0432.22488839
https://doi.org/10.1158/1078-0432.22488839
Autor:
Amod A. Sarnaik, Shari Pilon-Thomas, Vernon K. Sondak, James J. Mulé, Jeffrey S. Weber, Nikhil I. Khushalani, Jamie K. Teer, Michael J. Schell, Marjorie Colón Colón, Carolyn J. Rich, Allison D. Richards, Alberto J. Martinez, Benjamin Schachner, Doris Wiener, Holly Branthoover, Luz Nagle, Patrick Innamarato, Jamie Blauvelt, Matthew S. Beatty, Amy M. Hall, Cheryl A. Cox, John E. Mullinax, MacLean S. Hall
Supplementary Table 1 shows the distribution of Grade 3 and 4 non-hematologic adverse events reported in this study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb5a871859561fb70cfe92dcdaf6ddff
https://doi.org/10.1158/1078-0432.22488842
https://doi.org/10.1158/1078-0432.22488842
Autor:
Amod A. Sarnaik, Shari Pilon-Thomas, Vernon K. Sondak, James J. Mulé, Jeffrey S. Weber, Nikhil I. Khushalani, Jamie K. Teer, Michael J. Schell, Marjorie Colón Colón, Carolyn J. Rich, Allison D. Richards, Alberto J. Martinez, Benjamin Schachner, Doris Wiener, Holly Branthoover, Luz Nagle, Patrick Innamarato, Jamie Blauvelt, Matthew S. Beatty, Amy M. Hall, Cheryl A. Cox, John E. Mullinax, MacLean S. Hall
Data not shown in reference to related statements in manuscript.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79cf289ac6a4e1b0f316e521db6205fc
https://doi.org/10.1158/1078-0432.22488851.v1
https://doi.org/10.1158/1078-0432.22488851.v1
Autor:
Christopher W Dukes, Renata AM Rossetti, Jonathan A Hensel, Sebastian Snedal, Christopher L Cubitt, Michael J Schell, Martha Abrahamsen, Kimberly Isaacs-Soriano, Kayoko Kennedy, Leslie N Mangual, Junmin Whiting, Veronica Martinez-Brockhus, Jessica Y Islam, Julie Rathwell, Matthew Beatty, Amy M Hall, Daniel Abate-Daga, Anna R Giuliano, Shari Pilon-Thomas
Publikováno v:
Journal of Clinical Virology Plus, Vol 3, Iss 3, Pp 100158- (2023)
Background: The role of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) neutralizing antibody response from natural infection and vaccination, and the potential determinants of this response are poorly understood. Characterizing this
Externí odkaz:
https://doaj.org/article/3b1528d0197246a3b73884009294ee6d